-+ 0.00%
-+ 0.00%
-+ 0.00%

Biogen and Stoke Therapeutics Present Promising Phase 3 Data on Zorevunersen for Dravet Syndrome at EPNS Congress

Reuters·07/10/2025 11:00:41

Please log in to view news